Filing Details

Accession Number:
0001209191-21-002327
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-06 18:36:20
Reporting Period:
2021-01-04
Accepted Time:
2021-01-06 18:36:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401667 Puma Biotechnology Inc. PBYI Pharmaceutical Preparations (2834) 770683487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553037 Paul Richard Bryce C/O Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles CA 90024
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-04 6,548 $10.23 70,079 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.